Market Price

134.44 

2.11 1.6%

as of Aug 16 '19

52 Week Range:

90.64 135.45


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Equity (BVPS) 7.41
8.51
11.41
11.33
12.45
12.05
10.94
11.90
13.05
14.49
14.07
growth rate 14.8% 34.1% -0.7% 9.9% -3.2% -9.2% 8.8% 9.7% 11.0% -2.9%
Earnings BIT 201.68
260.59
303.71
331.95
385.12
411.41
409.24
435.87
456.73
560.26
635.99
growth rate 29.2% 16.6% 9.3% 16.0% 6.8% -0.5% 6.5% 4.8% 22.7% 13.5%
Avg.PE 21.46
24.81
21.41
18.28
21.51
21.19
22.22
28.05
32.93
49.24
36.48
growth rate 15.6% -13.7% -14.6% 17.7% -1.5% 4.9% 26.2% 17.4% 49.5% -25.9%
ROA 10.05
12.13
12.29
12.12
14.13
15.10
15.53
12.95
10.18
9.66
11.28
growth rate 20.7% 1.3% -1.4% 16.6% 6.9% 2.9% -16.6% -21.4% -5.1% 16.8%
ROE 13.33
15.82
15.04
15.27
19.09
20.50
21.10
21.47
18.73
15.70
19.59
growth rate 18.7% -4.9% 1.5% 25.0% 7.4% 2.9% 1.8% -12.8% -16.2% 24.8%
ROIC 11.73
14.67
13.59
12.60
14.92
16.38
17.04
13.76
12.53
11.98
15.17
growth rate 25.1% -7.4% -7.3% 18.4% 9.8% 4.0% -19.3% -8.9% -4.4% 26.6%
Cur. Ratio 3.17
3.15
6.19
5.38
2.52
5.77
5.40
2.22
4.57
2.08
2.06
growth rate -0.6% 96.5% -13.1% -53.2% 129.0% -6.4% -58.9% 105.9% -54.5% -1.0%
Quick Ratio 2.34
2.31
4.88
4.33
2.10
4.75
4.04
1.74
3.53
1.32
1.22
growth rate -1.3% 111.3% -11.3% -51.5% 126.2% -15.0% -56.9% 102.9% -62.6% -7.6%
Leverage 1.35
1.26
1.20
1.33
1.37
1.34
1.38
1.92
1.77
1.49
1.98
growth rate -6.7% -4.8% 10.8% 3.0% -2.2% 3.0% 39.1% -7.8% -15.8% 32.9%
Balance Sheet Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Acct.Receivable 212.10
226.90
274.40
305.03
365.81
359.59
362.57
382.09
450.53
497.02
538.32
growth rate 7.0% 20.9% 11.2% 19.9% -1.7% 0.8% 5.4% 17.9% 10.3% 8.3%
Acct.Payable 211.24
229.08
85.41
81.11
92.57
92.76
92.72
115.73
growth rate 8.5% -62.7% -5.0% 14.1% 0.2% 0.0% 24.8%
Cur.Assets 853.30
985.30
1,292.50
1,361.15
1,448.85
1,556.21
1,407.84
1,419.72
1,644.00
1,065.72
1,145.37
growth rate 15.5% 31.2% 5.3% 6.4% 7.4% -9.5% 0.8% 15.8% -35.2% 7.5%
Total Assets 1,508.00
1,626.40
2,068.90
2,137.87
2,210.72
2,360.96
2,181.77
3,256.71
3,468.49
3,063.92
4,107.68
growth rate 7.9% 27.2% 3.3% 3.4% 6.8% -7.6% 49.3% 6.5% -11.7% 34.1%
Cash 415.70
488.80
735.30
809.54
876.05
905.73
717.25
731.43
821.94
188.70
147.13
growth rate 17.6% 50.4% 10.1% 8.2% 3.4% -20.8% 2.0% 12.4% -77.0% -22.0%
Inventory 157.40
185.60
200.80
174.35
145.85
165.42
246.86
224.46
268.32
268.70
349.64
growth rate 17.9% 8.2% -13.2% -16.4% 13.4% 49.2% -9.1% 19.5% 0.1% 30.1%
Cur.Liabilities 269.10
312.70
208.80
252.85
574.05
269.56
266.46
637.99
360.13
511.25
555.99
growth rate 16.2% -33.2% 21.1% 127.0% -53.0% -1.2% 139.4% -43.6% 42.0% 8.8%
Liabilities 392.80
338.90
338.20
530.24
600.21
602.71
594.47
1,561.87
1,508.22
1,004.94
2,035.49
growth rate -13.7% -0.2% 56.8% 13.2% 0.4% -1.4% 162.7% -3.4% -33.4% 102.6%
LT Debt 94.20
0.00
100.00
250.78
0.77
300.77
300.59
873.33
1,078.61
269.99
1,258.86
growth rate -100.0% 150.8% -99.7% 39,011.8% -0.1% 190.5% 23.5% -75.0% 366.3%
Equity 1,115.20
1,287.50
1,730.70
1,607.63
1,610.52
1,758.25
1,587.31
1,694.83
1,960.27
2,058.98
2,072.19
growth rate 15.5% 34.4% -7.1% 0.2% 9.2% -9.7% 6.8% 15.7% 5.0% 0.6%
Common Shares 154.00
155.00
157.00
149.00
146.00
144.00
143.00
142.00
142.00
144.00
144.00
growth rate 0.7% 1.3% -5.1% -2.0% -1.4% -0.7% -0.7% 0.0% 1.4% 0.0%
Cash Flow Statement Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Capital Expenditures 107.90
56.90
66.60
47.14
63.58
72.72
62.50
58.53
62.22
62.58
68.71
growth rate -47.3% 17.1% -29.2% 34.9% 14.4% -14.1% -6.4% 6.3% 0.6% 9.8%
Cash Dividends 0.00
0.00
0.00
0.00
97.20
141.52
157.26
168.13
186.35
199.50
211.71
growth rate 45.6% 11.1% 6.9% 10.8% 7.1% 6.1%
Cash From OA 238.90
188.20
283.20
383.16
402.82
391.27
383.18
547.93
414.05
505.03
459.05
growth rate -21.2% 50.5% 35.3% 5.1% -2.9% -2.1% 43.0% -24.4% 22.0% -9.1%
FCF per Share 0.81
0.82
1.32
1.92
2.11
2.21
2.24
3.00
2.45
3.08
2.59
growth rate 1.2% 61.0% 45.5% 9.9% 4.7% 1.4% 33.9% -18.3% 25.7% -15.9%
Sale Purchase of Stock -330.25
-117.02
33.35
38.81
27.69
30.16
23.33
growth rate 0.0% 100.0% 16.4% -28.6% 8.9% -22.6%
FCF 125.00
127.00
208.00
322.00
331.00
310.00
311.00
480.00
343.00
434.00
382.00
growth rate 1.6% 63.8% 54.8% 2.8% -6.3% 0.3% 54.3% -28.5% 26.5% -12.0%
Income Statement Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Sales 920.70
1,092.40
1,243.10
1,368.52
1,514.46
1,554.97
1,678.91
1,838.71
2,066.74
2,340.20
2,606.57
growth rate 18.7% 13.8% 10.1% 10.7% 2.7% 8.0% 9.5% 12.4% 13.2% 11.4%
Op.Income 190.30
240.40
266.90
254.85
307.13
411.41
409.24
435.87
456.73
560.26
635.99
growth rate 26.3% 11.0% -4.5% 20.5% 34.0% -0.5% 6.5% 4.8% 22.7% 13.5%
IBT 201.70
260.60
303.70
331.95
385.12
431.08
435.92
439.57
418.74
521.31
518.85
growth rate 29.2% 16.5% 9.3% 16.0% 11.9% 1.1% 0.8% -4.7% 24.5% -0.5%
Net Income 146.40
190.10
227.00
254.85
307.13
345.27
352.89
352.41
342.28
315.59
404.59
growth rate 29.9% 19.4% 12.3% 20.5% 12.4% 2.2% -0.1% -2.9% -7.8% 28.2%
EPS 0.95
1.23
1.44
1.71
2.10
2.39
2.47
2.49
2.40
2.19
2.80
growth rate 29.5% 17.1% 18.8% 22.8% 13.8% 3.4% 0.8% -3.6% -8.8% 27.9%
Gross Profit 553.80
655.50
741.30
820.74
940.66
989.79
1,011.40
1,066.50
1,201.75
1,362.16
1,536.59
growth rate 18.4% 13.1% 10.7% 14.6% 5.2% 2.2% 5.5% 12.7% 13.4% 12.8%
R&D 63.10
75.20
92.00
109.73
144.89
118.23
114.87
118.65
144.47
155.15
180.65
growth rate 19.2% 22.3% 19.3% 32.0% -18.4% -2.8% 3.3% 21.8% 7.4% 16.4%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 154.39
144.13
163.20
156.98
171.68
growth rate -6.7% 13.2% -3.8% 9.4%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 483.68
476.60
490.82
521.85
538.32
growth rate -1.5% 3.0% 6.3% 3.2%
Acct.Payable 92.72
98.71
110.34
124.47
115.73
growth rate 6.5% 11.8% 12.8% -7.0%
Cur.Assets 1,065.72
1,088.24
1,063.54
1,102.70
1,145.37
growth rate 2.1% -2.3% 3.7% 3.9%
Total Assets 3,063.92
3,067.54
3,859.82
4,098.53
4,107.68
growth rate 0.1% 25.8% 6.2% 0.2%
Cash 188.70
230.19
149.47
146.51
147.13
growth rate 22.0% -35.1% -2.0% 0.4%
Inventory 268.70
282.56
296.51
319.93
349.64
growth rate 5.2% 4.9% 7.9% 9.3%
Cur.Liabilities 511.25
421.11
436.44
462.97
555.99
growth rate -17.6% 3.6% 6.1% 20.1%
Liabilities 1,004.94
1,167.28
1,903.77
2,077.20
2,035.49
growth rate 16.2% 63.1% 9.1% -2.0%
LT Debt 269.99
517.64
1,185.50
1,323.35
1,258.86
growth rate 91.7% 129.0% 11.6% -4.9%
Equity 2,058.98
1,900.26
1,956.04
2,021.33
2,072.19
growth rate -7.7% 2.9% 3.3% 2.5%
Common Shares 0.57
0.57
0.57
0.57
0.58
growth rate -0.2% 0.5% 0.0% 0.4%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 17.62
12.99
18.43
15.08
22.20
growth rate -26.3% 41.8% -18.2% 47.2%
Cash Dividends 49.97
52.79
52.77
53.03
53.12
growth rate 5.7% 0.0% 0.5% 0.2%
Cash From OA 129.42
48.12
129.47
139.65
141.82
growth rate -62.8% 169.1% 7.9% 1.6%
Sale Purchase of Stock 13.73
growth rate
FCF 111.80
35.13
111.04
124.56
119.62
growth rate -68.6% 216.1% 12.2% -4.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 623.63
588.28
651.10
662.23
704.96
growth rate -5.7% 10.7% 1.7% 6.5%
Op.Income 154.39
144.13
163.20
156.98
171.68
growth rate -6.7% 13.2% -3.8% 9.4%
IBT 140.92
138.88
146.27
137.93
95.77
growth rate -1.5% 5.3% -5.7% -30.6%
Net Income 109.81
105.74
124.64
105.42
68.80
growth rate -3.7% 17.9% -15.4% -34.7%
EPS
growth rate
Gross Profit 362.47
343.09
383.73
391.91
417.85
growth rate -5.4% 11.8% 2.1% 6.6%
R&D 39.66
38.79
43.11
47.61
51.14
growth rate -2.2% 11.1% 10.4% 7.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (53.93)

YOY Growth Grade:

D (49.23)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.48 43.10 28.89
EPS / Growth 6.5% 3.12 9.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.3% 6.6% 6.6%
Future PE 8.54 26.21 26.21
Future EPS 4.74 5.93 5.93
Value Price
MOS %
10.00
-92.6%
38.40
-71.4%
38.40
-71.4%
MOS Price 5.00 19.20 19.20
IRT 24.32 20.29 20.29

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.